Skip to main content

Advertisement

Log in

Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

The objective was to evaluate the surgical feasibility of opportunistic salpingectomy or salpingo-oophorectomy during benign vaginal hysterectomy (HV) and the prevalence of occult tubal lesions.

Methods

In this prospective study from 1 September 2013 to 1 November 2015, the prevalence of bilateral salpingectomy with or without ovariectomy and the prevalence of histopathological and immunohistochemical tubal abnormalities were assessed.

Results

A total 115 patients were included. Bilateral salpingectomy was performed in 85 patients (73.92%; group A) and was technically impossible in 30 patients (26.08%; group B). Older patients (62.9 vs 57.5 years, p = 0.009), menopausal status (83.33% vs 62.35%, p = 0.03) and elevated BMI (27.58 vs 25.05 p = 0.03) were statistically associated with failure of salpingectomy. There was only one case of postoperative hemorrhage in group A. There was no difference with regard to intra- or postoperative complications, blood loss, and operating time between the two groups. Among the 67 fallopian tubes analyzed with a validated histopathological protocol, there were 8 (11.94%) immunohistochemical abnormalities with a “p53 signature.”

Conclusions

With the recent demonstration of a tubal origin of most ovarian cancer, opportunistic salpingectomy could be a theoretically relevant prevention strategy. Bilateral salpingectomy could be performed during benign vaginal hysterectomy by experienced surgeons. The advantages and disadvantages of exclusive salpingectomy during pelvic floor surgery should be discussed with the patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Chene G, Rahimi K, Mes-Masson AM, Provencher D. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis. J Minim Invasive Gynecol. 2013;20:153–9.

    Article  PubMed  Google Scholar 

  2. Oliver Perez MR, Magrina J, Garcia AT, Jimenez Lopez JS. Prophylactic salpingectomy and prophylactic salpingooophorectomy for adnexal high-grade serous epithelial carcinoma: a reappraisal. Surg Oncol. 2015;24:335–44.

    Article  PubMed  Google Scholar 

  3. Walker JL, Powell CB, Chen LM, Carter J, Bae Jump VL, Parker LP, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer. 2015;121:2108–20.

  4. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230–6.

    Article  PubMed  Google Scholar 

  5. Chene G, Meysonnier C, Buenerd A, Moret S, Beaufils E, Le Bail-Carval K, et al. Feasibility of opportunistic salpingectomy at the time of vaginal hysterectomy for benign pathology and evaluation of occult tubal lesions prevalence: preliminary study. J Gynecol Obstet Biol Reprod (Paris). 2016;45:549–58.

  6. Davies A, O’Connor H, Magos AL. A prospective study to evaluate oophorectomy at the time of vaginal hysterectomy. Br J Obstet Gynaecol. 1996;103:915–20.

    Article  CAS  PubMed  Google Scholar 

  7. Kovac SR, Barhan S, Lister M, Tucker L, Bishop M, Das A. Guidelines for the selection of the route of hysterectomy : application in a resident clinic population. Am J Obstet Gynecol. 2002;187:1521–7.

    Article  PubMed  Google Scholar 

  8. Muller CY, Coleman RL, Toler K, Gibbons D, Ashfaq R, Voet RL. Adequacy of oophorectomy at the time of gynecologic surgery. Int J Gynaecol Obstet. 2002;77:23–9.

    Article  CAS  PubMed  Google Scholar 

  9. Bogani G, Cromi A, Serati M, Di Naro E, Casarin J, Pinelli C, et al. Laparoscopic and vaginal approaches to hysterectomy in the obese. Eur J Obstet Gynecol Reprod Biol. 2015;189:85–90.

  10. Karp DR, Mukati M, Smith AL, Suciu G, Aguilar VC, Davila GW. Predictors of successful salpingo-oophorectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2012;19:58–62.

    Article  PubMed  Google Scholar 

  11. Cho HY, Kang SW, Kim HB, Park SH, Park ST. Prophylactic adnexectomy along with vaginal hysterectomy for benign pathology. Arch Gynecol Obstet. 2012;286:1221–5.

    Article  PubMed  Google Scholar 

  12. Sheth SS. Adnexectomy for benign pathology at vaginal hysterectomy without laparoscopic assistance. Br J Obstet Gynaecol. 2002;109:1401–5.

    Article  Google Scholar 

  13. Robert M, Cenaiko D, Sepandj J, Iwanicki S. Success and complications of salpingectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2015;22:864–9.

    Article  PubMed  Google Scholar 

  14. Chene G, de Rochambeau B, Le Bail-Carval K, Beaufils E, Chabert P, Mellier G, et al. Current surgical practice of prophylactic and opportunistic salpingectomy in France. Gynecol Obstet Fertil. 2016;44:377–84.

  15. Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol. 2014;38:729–42.

    Article  PubMed  Google Scholar 

  16. Mehrad M, Ning G, Chen EY, Mehra KK, Crum CP. A pathologist’s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol. 2010;17:293–302.

    Article  CAS  PubMed  Google Scholar 

  17. McAlpine JN, Hanley GE, Woo MM, Tone AA, Rozenberg N, Swenerton KD, et al. Ovarian cancer research program of British Columbia. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014;210:471.e1–11.

  18. Kapurubandara S, Qin V, Gurram D, Anpalagan A, Merkur H, Hogg R, et al. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice. Aust NZ J Obstet Gynaecol. 2015;55:606–11.

  19. Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long term health outcomes in the nurses health study. Obstet Gynecol. 2010;113:1027–37.

    Article  Google Scholar 

  20. Dwyer PL. Ovarian cancer and the pelvic floor surgeon: the case for prophylactic bilateral salpingectomy during POP surgery. Int Urogynecol J. 2012;23:655–6.

    Article  PubMed  Google Scholar 

  21. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106:219–26.

    Article  PubMed  Google Scholar 

  22. Chene G, Lamblin G, Marcelli M, Huet S, Gauthier T. Urinary, infectious and digestive adverse events related to benign hysterectomy and the associated surgery on the fallopian tube: guidelines. J Gynecol Obstet Biol Reprod. 2015;44:1183–205.

    Article  CAS  Google Scholar 

  23. Repasy I, Lendvai V, Koppan A, Bodis J, Koppan M. Effect of the removal of the fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2009;144:64–7.

    Article  PubMed  Google Scholar 

  24. Ghezzi F, Cromi A, Siesto G, Bergamini V, Zefiro F, Bolis P. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG. 2009;116:589–93.

    Article  CAS  PubMed  Google Scholar 

  25. Morse AN, Hammer RA, Walter AJ, Baker S, Magtibay PM. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol. 2002;187:1483–6.

    Article  PubMed  Google Scholar 

  26. Vorwerg J, Radosa MP, Nicolaus K, Baus N, Jimenez Cruz J, Rengsberger M, et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and reoperation rate. J Cancer Res Clin Oncol. 2014;140:859–65.

  27. Venturella R, Lico D, Borelli M, Imbrogno MG, Cevenini G, Zupi E, et al. 3 to 5 years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function. J Minim Invasive Gynecol. 2017;24:145–50.

  28. Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis. Eur J Cancer. 2016;55:38–46.

    Article  PubMed  Google Scholar 

  29. Darelius A, Lycke M, Kindblom JM, Kristjansdottir B, Sundfeldt K, Strandell A. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review. BJOG. 2017;124:880–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank our two expert pathologists for the histopathological analyses: Dr Annie Buenerd and Dr Beatrice Nadaud.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gautier Chene.

Ethics declarations

Conflicts of interest

None.

Funding source

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lamblin, G., Meysonnier, C., Moret, S. et al. Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition. Int Urogynecol J 29, 715–721 (2018). https://doi.org/10.1007/s00192-017-3418-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-017-3418-0

Keywords

Navigation